Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROA

Below are the top diagnostic substances stocks on the NASDAQ in terms of return on assets.

The trailing-twelve-month return on assets at Meridian Bioscience (NASDAQ: VIVO) is 21.50%. Meridian Bioscience's revenue for the same period is $188.10 million.

The trailing-twelve-month return on assets at IDEXX Laboratories (NASDAQ: IDXX) is 19.70%. IDEXX Laboratories' operating margin for the same period is 19.40%.

The trailing-twelve-month return on assets at Neogen (NASDAQ: NEOG) is 15.90%. Neogen's EPS for the same period is $0.75.

The trailing-twelve-month return on assets at SurModics (NASDAQ: SRDX) is 14.30%. SurModics' PEG ratio is 1.57.